Petra Spornraft-Ragaller
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Petra Spornraft-Ragaller has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
Jochen Schmitt
Zentrum für Evidenzbasierte Gesundheitsversorgung, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden
3 shared publicationsS. Esser
Klinik für Dermatologie und Venerologie, Universitätsklinikum Essen, Essen, Deutschland
3 shared publicationsStefan Beissert
Klinik und Poliklinik für Dermatologie Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden
3 shared publicationsU. Boashie
Klinik und Poliklinik für Dermatologie, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Dresden, Deutschland
3 shared publicationsUte Boashie
Klinik und Poliklinik für Dermatologie, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden
2 shared publicationsVictoria Stephan
Zentrum für Evidenzbasierte Gesundheitsversorgung, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden
2 shared publications
Latest Publications
- 1 January 2023
- Published by Springer Nature
- p. 37-49
Bakterielle Infektionen
- 22 July 2022
- Published by Georg Thieme Verlag KG in Aktuelle Dermatologie
- Vol. 48 (07) , 317-320
Therapie mit Upadacitinib bei schwerem atopischen Ekzem bei Komorbidität einer ankylosierenden Spondylitis und reaktiven Uveitis
Zusammenfassung: Die atopische Dermatitis (AD) stellt mit einer Lebenszeitprävalenz von bis zu 20% die häufigste chronisch-entzündliche Hauterkrankung des Menschen dar. Die Leitsymptome sind quälender Pruritus und wiederkehrende ekzematöse Hautläsionen. Eine moderne therapeutische Option stellt die Modulation des JAK-STAT-Signalweges mit oralen JAK-Inhibitoren (JAKIs) dar. Wir berichten über einen 62-jährigen kaukasischen Patienten mit schwerer AD bei Komorbidität einer ankylosierenden Spondylitis und rezidivierenden Uveitiden, der sich nach Einleitung einer oralen Therapie mit Upadacitinib in anhaltender Remission sowohl der AD als auch der Komorbidität befindet.
- 22 July 2022
- Published by Georg Thieme Verlag KG in Aktuelle Dermatologie
- Vol. 48 (07) , 317-320
Therapie mit Upadacitinib bei schwerem atopischen Ekzem bei Komorbidität einer ankylosierenden Spondylitis und reaktiven Uveitis
Zusammenfassung: Die atopische Dermatitis (AD) stellt mit einer Lebenszeitprävalenz von bis zu 20% die häufigste chronisch-entzündliche Hauterkrankung des Menschen dar. Die Leitsymptome sind quälender Pruritus und wiederkehrende ekzematöse Hautläsionen. Eine moderne therapeutische Option stellt die Modulation des JAK-STAT-Signalweges mit oralen JAK-Inhibitoren (JAKIs) dar. Wir berichten über einen 62-jährigen kaukasischen Patienten mit schwerer AD bei Komorbidität einer ankylosierenden Spondylitis und rezidivierenden Uveitiden, der sich nach Einleitung einer oralen Therapie mit Upadacitinib in anhaltender Remission sowohl der AD als auch der Komorbidität befindet.
- Open Access
- 25 November 2021
- Published by Wiley in JDDG: Journal der Deutschen Dermatologischen Gesellschaft
- Vol. 19 (12) , 1784-1785
Intraoperative anaphylaxis to atracurium
- 25 November 2021
- Published by Wiley in JDDG: Journal der Deutschen Dermatologischen Gesellschaft
- Vol. 19 (12) , 1784-1785
Open AccessIntraoperative anaphylaxis to atracurium
- Open Access
- 10 August 2021
- Published by MDPI AG in Antibiotics
- Vol. 10 (8) , 962
Antibiotic Resistance and Genotypes of Mycoplasma genitalium during a Resistance-Guided Treatment Regime in a German University Hospital
The treatment of infections from the sexually transmitted pathogen Mycoplasma genitalium is hampered by the rapidly increasing resistance to the recommended first- (macrolides) and second-line antibiotics (quinolones). Thus, resistance-guided therapy (RGT) is key for its successful eradication but the efficiency of this approach can be influenced by re-infections and treatment failures. The typing of strains is helpful to distinguish between ongoing colonization, re-infection or the development of resistance. In the present study, mgpB and MG_309 types as well as mutations associated with macrolide, quinolone and tetracycline resistance of strains in M. genitalium-positive samples accumulated in the years 2019 and 2020 at a university hospital were analyzed. Fifty-eight positive first and sixteen positive follow-up samples from patients (96.6% male, 84.5% men who have sex with men, 74.1% HIV-positive) were included. Twenty-three mgpB types (seven new types), nine MG_309 types and thirty-four mgpB/MG_309 types were identified. The prevalence of mutations associated with macrolide, quinolone and tetracycline resistance was 56.9%, 10.3% and 6.8%, respectively. Despite the fact that many asymptomatic patients were not treated and tests of cure were impossible in different cases, the preliminary rate of successful eradication (93.3%) in this study is promising for the continuation of the RGT strategy.
- 10 August 2021
- Published by MDPI AG in Antibiotics
- Vol. 10 (8) , 962
Open AccessAntibiotic Resistance and Genotypes of Mycoplasma genitalium during a Resistance-Guided Treatment Regime in a German University Hospital
The treatment of infections from the sexually transmitted pathogen Mycoplasma genitalium is hampered by the rapidly increasing resistance to the recommended first- (macrolides) and second-line antibiotics (quinolones). Thus, resistance-guided therapy (RGT) is key for its successful eradication but the efficiency of this approach can be influenced by re-infections and treatment failures. The typing of strains is helpful to distinguish between ongoing colonization, re-infection or the development of resistance. In the present study, mgpB and MG_309 types as well as mutations associated with macrolide, quinolone and tetracycline resistance of strains in M. genitalium-positive samples accumulated in the years 2019 and 2020 at a university hospital were analyzed. Fifty-eight positive first and sixteen positive follow-up samples from patients (96.6% male, 84.5% men who have sex with men, 74.1% HIV-positive) were included. Twenty-three mgpB types (seven new types), nine MG_309 types and thirty-four mgpB/MG_309 types were identified. The prevalence of mutations associated with macrolide, quinolone and tetracycline resistance was 56.9%, 10.3% and 6.8%, respectively. Despite the fact that many asymptomatic patients were not treated and tests of cure were impossible in different cases, the preliminary rate of successful eradication (93.3%) in this study is promising for the continuation of the RGT strategy.
- 1 January 2021
- Published by Elsevier
- p. 755-777
Sexuell übertragbare Infektionen (STI) und HIV/AIDS
- 1 June 2020
- Vol. 162, 44-48
[Rapid testing for sexually transmitted infections].
- 5 February 2020
- Published by Springer Nature in Die Dermatologie
- Vol. 71 (4) , 275-283
Klassische sexuell übertragbare Infektionen im Analbereich
Sexuell übertragbare Infektionen (STI) im Anorektalbereich treten bei Risikopopulationen wie Männern, die Sex mit Männern haben (MSM), überproportional häufig auf, finden sich aber durch ein geändertes Sexualverhalten zunehmend auch bei Heterosexuellen. Nach kürzlicher Implementierung der medikamentösen HIV(„human immunodeficiency virus“)-Präexpositionsprophylaxe ist mit einer weiteren Zunahme von STI zu rechnen, da hierbei meist auf Kondome verzichtet wird.
- 5 February 2020
- Published by Springer Nature in Die Dermatologie
- Vol. 71 (4) , 275-283
Klassische sexuell übertragbare Infektionen im Analbereich
Sexuell übertragbare Infektionen (STI) im Anorektalbereich treten bei Risikopopulationen wie Männern, die Sex mit Männern haben (MSM), überproportional häufig auf, finden sich aber durch ein geändertes Sexualverhalten zunehmend auch bei Heterosexuellen. Nach kürzlicher Implementierung der medikamentösen HIV(„human immunodeficiency virus“)-Präexpositionsprophylaxe ist mit einer weiteren Zunahme von STI zu rechnen, da hierbei meist auf Kondome verzichtet wird.
- Open Access
- 28 January 2020
- Published by Springer Nature in Infection
- Vol. 48 (2) , 259-265
Prevalence and antibiotic resistance of rectal Mollicutes in HIV-infected men who have sex with men at the University Hospital of Dresden, Germany
Background: Rectal sexually transmitted infections (STI) are common in men having sex with men (MSM). Mycoplasma genitalium is increasingly being reported in this localization, but due to frequent lack of symptoms at this site, clinical significance is still unclear. Rectal prevalence of Mycoplasma hominis and Ureaplasma species is not well studied so far. We aimed to investigate the prevalence and antibiotic sensitivity of rectal Mollicutes in our HIV-cohort. Methods: In 227 MSM presenting for annual STI-screening, 317 anorectal swabs were collected from January 2017 to December 2018. PCR was performed for detection of Chlamydia trachomatis, Neisseria gonorrhoeae, M. genitalium and also culture for M. hominis and Ureaplasma spec. Results: Prevalence for M. genitalium, M. hominis, Ureaplasma spec., C. trachomatis and N. gonorrhoeae was 8.2%, 7.3%, 12.0%, 5.1% and 1.9%, respectively. Patients were asymptomatic with few exceptions. Seroprevalence of syphilis in 227 MSM was 41.9%. In 20 strains of M. genitalium, resistance-associated mutations to macrolides and quinolones were found in 60% and 30%, respectively; in five strains (25%) to both. M. hominis and Ureaplasma spec. frequently occurred combined, mostly in significant quantity consistent with infection. M. hominis and Ureaplasma spec. regularly showed sensitivity to tetracycline. Conclusion: At screening, rectal colonization with Mollicutes was common in our patients, but rarely caused symptoms. Due to rising antibiotic resistance of M. genitalium against quinolones, therapeutic options are increasingly limited. Treatment should be guided by antibiotic resistance testing including quinolones. In persisting anorectal symptoms, M. hominis and Ureaplasma spec. should also be taken into account.
- 28 January 2020
- Published by Springer Nature in Infection
- Vol. 48 (2) , 259-265
Open AccessPrevalence and antibiotic resistance of rectal Mollicutes in HIV-infected men who have sex with men at the University Hospital of Dresden, Germany
Background: Rectal sexually transmitted infections (STI) are common in men having sex with men (MSM). Mycoplasma genitalium is increasingly being reported in this localization, but due to frequent lack of symptoms at this site, clinical significance is still unclear. Rectal prevalence of Mycoplasma hominis and Ureaplasma species is not well studied so far. We aimed to investigate the prevalence and antibiotic sensitivity of rectal Mollicutes in our HIV-cohort. Methods: In 227 MSM presenting for annual STI-screening, 317 anorectal swabs were collected from January 2017 to December 2018. PCR was performed for detection of Chlamydia trachomatis, Neisseria gonorrhoeae, M. genitalium and also culture for M. hominis and Ureaplasma spec. Results: Prevalence for M. genitalium, M. hominis, Ureaplasma spec., C. trachomatis and N. gonorrhoeae was 8.2%, 7.3%, 12.0%, 5.1% and 1.9%, respectively. Patients were asymptomatic with few exceptions. Seroprevalence of syphilis in 227 MSM was 41.9%. In 20 strains of M. genitalium, resistance-associated mutations to macrolides and quinolones were found in 60% and 30%, respectively; in five strains (25%) to both. M. hominis and Ureaplasma spec. frequently occurred combined, mostly in significant quantity consistent with infection. M. hominis and Ureaplasma spec. regularly showed sensitivity to tetracycline. Conclusion: At screening, rectal colonization with Mollicutes was common in our patients, but rarely caused symptoms. Due to rising antibiotic resistance of M. genitalium against quinolones, therapeutic options are increasingly limited. Treatment should be guided by antibiotic resistance testing including quinolones. In persisting anorectal symptoms, M. hominis and Ureaplasma spec. should also be taken into account.
- 8 November 2018
- Published by Springer Nature in Die Dermatologie
- Vol. 69 (12) , 1006-1013
Sexuell übertragbare Infektionen und männliche Fertilität
Sexuell übertragbare Infektionen (STI) sind weltweit häufig und können Einschränkungen der Fertilität bewirken. Bei Frauen sind Entzündungen des kleinen Beckens mit hierdurch resultierender tubarer Sterilität hierdurch gut belegt; bei Männern wird der Einfluss von STI auf die Fertilität nach wie vor kontrovers diskutiert.
- 8 November 2018
- Published by Springer Nature in Die Dermatologie
- Vol. 69 (12) , 1006-1013
Sexuell übertragbare Infektionen und männliche Fertilität
Sexuell übertragbare Infektionen (STI) sind weltweit häufig und können Einschränkungen der Fertilität bewirken. Bei Frauen sind Entzündungen des kleinen Beckens mit hierdurch resultierender tubarer Sterilität hierdurch gut belegt; bei Männern wird der Einfluss von STI auf die Fertilität nach wie vor kontrovers diskutiert.
- 26 April 2016
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 174 (4) , 717-718
Human papillomavirus is a risk factor for asymptomatic bacterial sexually transmitted infections in HIV-infected men who have sex with men
- 26 April 2016
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 174 (4) , 717-718
Human papillomavirus is a risk factor for asymptomatic bacterial sexually transmitted infections in HIV-infected men who have sex with men